DNTH
Dianthus Therapeutics, Inc.
Stock
$88.21−0.11 (−0.12%)Close Oct 2, 2026
- Capital expenditures, 2025
- $213K
- YoY, 2025
- +102.9%
- 5-year CAGR
- −11.8%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $213K | +102.9% |
| 2024 | $105K | −4.5% |
| 2023 | $110K | −65.0% |
| 2022 | $314K | −75.2% |
| 2021 | $1.3M | +216.0% |
| 2020 | $400K | −86.9% |
| 2019 | $3.1M | −60.1% |
| 2018 | $7.7M | +248.9% |
| 2017 | $2.2M | +1,482.0% |
| 2016 | $139K | — |